Veracyte Inc (NASDAQ:VCYT) achieved a 14% year-over-year revenue growth, reaching approximately $132 million. The company's core testing business saw an 18% revenue growth, driven by a 26% increase in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results